Non-Small Cell Lung Cancer New Reference: Maintenance Atezolizumab for Stage IB-IIIA NSCLC Ulas D. Bayraktar, MD 2025-06-02
Chronic Lymphocytic Leukemia New Protocol: Zanubrutinib with Venetoclax for Untreated CLL Ulas D. Bayraktar, MD 2025-06-02
Acute myeloid leukemia New Protocol: Venetoclax with Decitabine for AML Induction in Fit Patients Ulas D. Bayraktar, MD 2025-06-02
GastroEsophageal Cancer New Reference: Trastuzumab Deruxtecan for her2+ Gastric Cancer Ulas D. Bayraktar, MD 2025-06-02
Non-Small Cell Lung Cancer New Reference: Taletrectinib for ROS1+ NSCLC Ulas D. Bayraktar, MD 2025-06-02
Bladder Cancer New Indication: Neoadjuvant Durvalumab with CISplatin/Gemcitabine for Upper GU Tract Cancer Ulas D. Bayraktar, MD 2025-05-05
Breast Cancer New Protocol: Neoadj Pembrolizumab + TP for her2+ Breast Cancer Ulas D. Bayraktar, MD 2025-05-05
Colorectal Cancer New Reference: Neoadjuvant FOLFOX + Panitumumab for Colon Cancer Ulas D. Bayraktar, MD 2025-05-05
